MetLife, Inc.

New York Stock Exchange
Back to all articles
Slightly Bullish +13

Assessing MetLife (MET) Valuation After Recent Share Volatility And Longer Term Returns

AI-generated analysis

📉 MetLife (MET) stock declined 0.6% over the past day and gained slightly over the past week amid recent volatility.

⚠️ The stock has experienced weak share price returns over recent months with a 11.95% drop in the past 90 days and year-to-date.

📈 Long-term performance remains positive with a 3-year total shareholder return of 31.37%.

💰 MetLife is trading at $70.72 against an indicated intrinsic value discount of 51.65%.

🎯 The stock trades below the average analyst target price of $90.50.

🌏 Strategic growth opportunities exist in high-potential international markets like Asia, Latin America, and EMEA.

💵 The fair value model assumes disciplined capital use, ongoing buybacks, and steady top-line expansion rather than aggressive forecasts.

⚠️ Risks include interest rate volatility impacting investment margins and potential commercial mortgage loan losses.

📊 Simply Wall St's analysis concludes MetLife is currently undervalued with a fair value of $90.50.

💡 Investors are encouraged to scan broader screens for 20 founder-led companies, 62 high quality undervalued stocks, and 12 dividend fortresses.

📝 This article serves as general commentary based on historical data and analyst forecasts and is not financial advice.

Bullish Signals
  • MetLife's 3-year total shareholder return of 31.37% significantly outperforms its recent short-term decline, highlighting strong underlying long-term value.
  • The stock trades at an indicated intrinsic value discount of 51.65% below a fair value target of $90.50, presenting a compelling buying opportunity.
  • Strong sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA positions the company for robust long-term revenue expansion.
  • The company's playbook assumes disciplined capital use and ongoing buybacks to support steady top line expansion and firmer profit margins.
Risk Factors
  • ,.
  • ,.
  • ,.
  • ,.
Full Analysis
MetLife (MET) has recently attracted investor attention following share price volatility, recording a 0.6% decline over the past day and a modest gain over the past week. However, broader performance metrics indicate mixed short-term trends, with both the 90-day and year-to-date share price returns showing an 11.95% decline in contrast to a stronger 3-year total shareholder return of 31.37%. Currently trading at $70.72, the stock presents an indicated intrinsic value discount of 51.65% against an average analyst target price of $90.50, leading Simply Wall St to frame the current valuation primarily as earnings-driven rather than sentiment-driven. The analysis suggests MetLife is undervalued with a fair value target of $90.50, supported by strong, sustained premium and sales growth in high-potential international markets including Asia, Latin America, and EMEA. This long-term growth potential is positioned to capitalize on growing middle-class wealth and increased insurance penetration, which supports robust revenue and top-line expansion. The fair value narrative relies on a detailed playbook blending steady top-line expansion, firmer profit margins, and disciplined capital use through future buybacks rather than aggressive blue sky forecasts. Despite the undervalued stance, the investment thesis carries specific risks that could alter the valuation dynamics. The primary concerns include interest rate volatility that could pressure investment margins, as well as commercial mortgage loan losses and reserve builds that may strain earnings and capital reserves. Simply Wall St advises investors to weigh these factors carefully and consult a full narrative to understand the forecasts behind the fair value calculation, noting that this analysis uses historical data and analyst forecasts without constituting financial advice or accounting for the latest price-sensitive announcements.